Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results
about
Volumetric modulated arc therapy for treatment of solid tumors: current insights.Utilization of hypofractionated whole-breast radiation therapy in patients receiving chemotherapy: a National Cancer Database analysis.Dosimetric trade-offs in breast treatment with VMAT technique.Critical appraisal of the role of volumetric modulated arc therapy in the radiation therapy management of breast cancer.Advantages of a technique using two 50 degree arcs in simultaneous integrated boost radiotherapy for left-sidebreast cancer.Chair Heterogeneity Index: Describing the dose heterogeneity inside the tumor volume where there is a boost volume.
P2860
Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phase II trial of hypofraction ...... toxicity and clinical results
@en
Phase II trial of hypofraction ...... toxicity and clinical results.
@nl
type
label
Phase II trial of hypofraction ...... toxicity and clinical results
@en
Phase II trial of hypofraction ...... toxicity and clinical results.
@nl
prefLabel
Phase II trial of hypofraction ...... toxicity and clinical results
@en
Phase II trial of hypofraction ...... toxicity and clinical results.
@nl
P2093
P2860
P50
P1433
P1476
Phase II trial of hypofraction ...... toxicity and clinical results
@en
P2093
Cristina Iftode
Davide Franceschini
Elisa Villa
Fiorenza De Rose
Francesca Lobefalo
Giuseppe D'Agostino
Luca Cozzi
Piera Navarria
Stefano Tomatis
P2860
P2888
P356
10.1186/S13014-016-0701-Z
P577
2016-09-17T00:00:00Z
P6179
1028967471